Invesco Ltd. Illumina, Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Illumina, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 1,353,077 shares of ILMN stock, worth $132 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,353,077

Previous 908,534 48.93%

Holding current value

$132 Million

Previous $72.1 Million 79.09%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$70.3 - $95.41 $31.3 Million - $42.4 Million	444,543 Added 48.93%	1,353,077 $129 Million
Q1 2025 May 12, 2025	BUY	$79.34 - $144.22 $27.4 Million - $49.7 Million	344,795 Added 61.16%	908,534 $72.1 Million
Q4 2024 Feb 13, 2025	SELL	$128.99 - $155.15 $65.4 Million - $78.7 Million	-507,043 Reduced 47.35%	563,739 $75.3 Million
Q3 2024 Nov 12, 2024	SELL	$105.28 - $135.9 $23 Million - $29.6 Million	-218,095 Reduced 16.92%	1,070,782 $140 Million
Q2 2024 Aug 13, 2024	SELL	$101.05 - $133.57 $120 Million - $159 Million	-1,188,905 Reduced 47.98%	1,288,877 $135 Million
Q1 2024 May 14, 2024	SELL	$127.73 - $147.2 $16.7 Million - $19.3 Million	-131,077 Reduced 5.02%	2,477,782 $340 Million
Q4 2023 Feb 12, 2024	BUY	$92.79 - $142.53 $37.1 Million - $56.9 Million	399,450 Added 18.08%	2,608,859 $363 Million
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $20.6 Million - $30.7 Million	159,752 Added 7.79%	2,209,409 $303 Million
Q2 2023 Aug 11, 2023	BUY	$183.43 - $232.67 $35.1 Million - $44.5 Million	191,197 Added 10.29%	2,049,657 $384 Million
Q1 2023 May 12, 2023	BUY	$193.75 - $232.55 $14.3 Million - $17.1 Million	73,683 Added 4.13%	1,858,460 $432 Million
Q4 2022 Feb 13, 2023	SELL	$187.24 - $242.74 $26.2 Million - $33.9 Million	-139,735 Reduced 7.26%	1,784,777 $361 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $43.9 Million - $56.3 Million	247,533 Added 14.76%	1,924,512 $367 Million
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $15.2 Million - $30.8 Million	-83,748 Reduced 4.76%	1,676,979 $309 Million
Q1 2022 May 16, 2022	BUY	$303.87 - $423.8 $32 Million - $44.6 Million	105,347 Added 6.36%	1,760,727 $615 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $65.6 Million - $79.7 Million	189,030 Added 12.89%	1,655,380 $630 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $26.6 Million - $34.4 Million	65,545 Added 4.68%	1,466,350 $595 Million
Q2 2021 Aug 17, 2021	SELL	$372.84 - $481.5 $23.3 Million - $30.1 Million	-62,424 Reduced 4.27%	1,400,805 $663 Million
Q1 2021 May 17, 2021	SELL	$361.28 - $504.76 $3.96 Million - $5.53 Million	-10,960 Reduced 0.74%	1,463,229 $562 Million
Q4 2020 Feb 16, 2021	BUY	$292.7 - $370.96 $60.5 Million - $76.7 Million	206,837 Added 16.32%	1,474,189 $545 Million
Q3 2020 Nov 16, 2020	SELL	$268.51 - $400.74 $69 Million - $103 Million	-256,870 Reduced 16.85%	1,267,352 $392 Million
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $39.4 Million - $57.3 Million	-153,728 Reduced 9.16%	1,524,222 $564 Million
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $7.66 Million - $12.3 Million	-36,599 Reduced 2.13%	1,677,950 $458 Million
Q4 2019 Feb 14, 2020	SELL	$288.29 - $335.49 $376 Million - $437 Million	-1,303,571 Reduced 43.19%	1,714,549 $569 Million
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $91.7 Million - $130 Million	343,712 Added 12.85%	3,018,120 $918 Million
Q2 2019 Aug 14, 2019	BUY	$300.59 - $368.15 $14.2 Million - $17.4 Million	47,144 Added 1.79%	2,674,408 $985 Million
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $19.9 Million - $23.5 Million	-73,068 Reduced 2.71%	2,627,264 $816 Million
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $736 Million - $990 Million	2,700,332 New	2,700,332 $810 Million

Others Institutions Holding ILMN

# of Institutions

876

Shares Held

152M

Call Options Held

1.67M

Put Options Held

1.36M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $15.3B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account